Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

Detecting breast cancer's fingerprint in a droplet of blood

April 6, 2012 5:28 am | News | Comments

One in eight women will be diagnosed with breast cancer during her lifetime. The earlier cancer is detected, the better the chance of successful treatment and long-term survival. However, early cancer diagnosis is still challenging as testing by mammography remains cumbersome...

Tiny hitchhikers attack cancer cells

April 5, 2012 7:21 am | News | Comments

Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus...

Mobile technology helps explore nicotine addiction

April 4, 2012 7:33 am | News | Comments

Some people quit smoking on the first try while others have to quit repeatedly. Using such mobile technology as hand-held computers and smartphones, a team of researchers from Penn State and the University of Pittsburgh is trying to find out why.

Advertisement

Medgenics Cleared to Initiate Phase IIa Anemia Study of EPODURE Biopump in Dialysis Patients in Israel

March 23, 2012 10:58 am | News | Comments

MISGAV, Israel and SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health...

Itamar-Medical Launches Next-Generation, Cardiovascular Health Assessment Platform

March 22, 2012 11:41 am | News | Comments

CAESAREA, Israel--(BUSINESS WIRE)--Itamar-Medical, the leading provider of diagnostic devices for cardiovascular disease and sleep apnea based on its proprietary PAT® signal technology, will unveil its cardiovascular healthcare assessment platform, EndoPAT-MF, at the upcoming...

Curetis AG to Present Its Unyvero System for Pneumonia Diagnostics

March 22, 2012 7:28 am | News | Comments

Holzgerlingen, Germany -- Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, today announced the presentation of its Unyveroâ„¢ System and the Unyveroâ„¢ P50 Pneumonia Cartridge...

Electronic Medical Records Help Keep Costs Down, Say Struggling Hospitals

March 22, 2012 7:20 am | News | Comments

NEW YORK (GBI Research) - Unhealthy modern lifestyles, ageing populations and struggling national health services will combine to create huge demand for Electronic Medical Records (EMR), according to a new report by medical intelligence company GBI Research.

Irish Hospital Uses Elekta's Clarity 3D Ultrasound to Guide Prostate Cancer Radiotherapy

March 8, 2012 5:30 am | News | Comments

Soft tissue imaging with 3D ultrasound both at therapy simulation and just before treatment has transformed prostate radiotherapy at University Hospital Galway (UHG). The majority of radiotherapy patients with prostate cancer who visit the clinic will benefit from a new technology...

Advertisement

Mayo Clinic Announces Collaboration on New Progranulin Blood Test for Dementia

March 6, 2012 8:20 am | News | Comments

Mayo Clinic today announced that Mayo Medical Laboratories has signed an agreement with A&G Pharmaceutical, Inc. and will receive a non-exclusive license to certain patent rights and proprietary antibody reagents for the detection and measurement of progranulin in blood.

Preventing Protein Build Up on In-Vivo Devices and Biosensors

March 5, 2012 11:32 am | by John Marugg, Ph.D. | Articles | Comments

Biosensors are critical components of diagnostic devices. They are tiny, integrated circuit chips that transmit readings from within the body to an external component that displays data for physicians and patients. Biosensors have many applications including important roles in continuous glucose monitors, sensors that monitor cell health, and magnetic sensors associated with microlabels and microfluidic cartridges, just to name a few. A big obstacle facing biosensors that are implanted into the body is longevity.

Thermo Fisher Scientific Extends PCT Assay Licensing Agreement with Wako Pure Chemical Industries, Ltd.

February 22, 2012 4:49 am | News | Comments

WALTHAM, Mass. – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has extended its licensing agreement with Wako Pure Chemical Industries, Ltd. to ensure continued use of the Thermo Scientific B·R·A·H·M·S PCT assay on Wako laboratory systems...

Philips Vital Signs Camera app

February 12, 2012 8:43 am | by Philips | Videos | Comments

The Vital Signs Camera app from Philips (http://www.vitalsignscamera.com) performs a contactless measurement of your heart rate and breathing rate, simply by using the camera of your iPad 2. This breakthrough technology allows you to measure your vital signs in an easy and unobtrusive way...

CLSI Publishes New Guideline Describing the Principles of Estimating Measurement Uncertainty

February 10, 2012 4:57 am | News | Comments

Wayne, Pennsylvania, USA-The Clinical and Laboratory Standards Institute (CLSI) recently published Expression of Measurement Uncertainty in Laboratory Medicine; Approved Guideline (C51-A). This document describes a practical approach to assist clinical laboratories and in vitro diagnostic...

Advertisement

New Uses of Adhesives in Durable Medical Diagnostic Equipment

February 9, 2012 8:46 am | by Jeremy Cooler | Articles | Comments

Design engineers for medical diagnostic equipment are acutely aware of the dramatic growth and change in the healthcare industry. Medical OEMs and contract manufacturers are looking for suppliers who can help them meet new industry and federal regulations, achieve the highest quality products, support new care approaches (including patient-controlled monitoring and treatment), and drive down manufacturing costs.

Cellnovo Launches World's F?rst Mob?le-Connected D?abetes Management System

February 9, 2012 4:40 am | News | Comments

LONDON UK. Cellnovo today announced both the commercial launch of the world's only mobile-connected diabetes management system, and the start of the largest usability trial ever to investigate insulin pump technology for patients with type 1 diabetes. The trial will also be the first in...

Gently Removing and Long-Term Wear Adhesives

February 8, 2012 9:39 am | Product Releases | Comments

Adhesives Research, a leading developer and manufacturer of adhesive products, invites OEMs and product designers to learn about its newest adhesive technology for wound care and medical device products...

Sensable Customers Showcase Touch-Enabled Surgical, Medical Simulation and Robotics Innovations at MMVR Conference

February 8, 2012 5:21 am | News | Comments

WILMINGTON, Mass.--(BUSINESS WIRE)--Sensable's customers will feature prominently at the Medicine Meets Virtual Reality (MMVR) Conference in Newport Beach, California beginning tomorrow, where they will showcase innovative haptically-enabled surgical, medical simulation...

‘Camera in a Pill' Endoscopy Sees Increasing Acceptance and Sales

February 7, 2012 5:20 am | News | Comments

New York-Driven by innovative devices such as capsule endoscopes, the entire gastrointestinal device market grew to $14.6 billion in 2011, according to healthcare market research publisher Kalorama Information. Capsule endoscopy has been one of the fastest areas of revenue growth for manufacturers...

T2 Biosystems Announces Issuance of Key Patent Providing Broad Intellectual Property Protection for Direct Detection Diagnostic Methods

February 3, 2012 5:29 am | News | Comments

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled “NMR Device for Detection of Analytes.”

Light-activatable Substances – a new Weapon in the Fight against Cancer

February 3, 2012 5:12 am | News | Comments

Frankfurt – On February 4, World Cancer Day, the public attention for the fight against cancer will be raised once more: In Germany alone, 400.000 new instances of cancer are counted every year. The good news: More and more people affected can be helped effectively.

Targeting tumors may help stop spread of breast, other cancers

February 3, 2012 4:38 am | News | Comments

GAINESVILLE, Fla. - Cancer that has spread from the site of an original tumor to other places in the body is often viewed as a death sentence. But if there are just a few of those secondary tumors, called metastases, some patients have a good chance of survival if treated with...

Health Discovery Corporation Launches Android Version of Popular MelApp, Melanoma Risk Analysis Mobile Phone App

February 2, 2012 5:00 am | News | Comments

SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation, the molecular diagnostics company that launched MelApp, the first SVM-based image analysis iPhone app for melanoma risk assessment, today debuts its popular MelApp mobile app for Androidâ„¢ devices.

US Demand for Drug Delivery Products to Reach $134 Billion in 2015

February 1, 2012 5:34 am | News | Comments

US demand for drug delivery products will expand 7.4 percent annually to $134 billion in 2015. The best growth opportunities will emerge in dosage formulations that advance the nature of therapy for autoimmune conditions, cancer, heart disease, neurological disorders...

Singapore Scientists Lead in 3D Mapping of Human Genome to Help Understand Human Diseases

February 1, 2012 5:20 am | News | Comments

Singapore - (ACN Newswire) - Genome Institute of Singapore's (GIS) Associate Director of Genomic Technologies, Dr Yijun RUAN, led a continuing study on the human genome spatial/structural configuration, revealing how genes interact/communicate and influence each other, even when...

Roche Receives FDA Clearance for Test to Screen and Diagnose Chlamydia and Gonorrhea Infection in Symptomatic and Asymptomatic Patients

February 1, 2012 5:15 am | News | Comments

PLEASANTON, Calif./PRNewswire/ -- Roche announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas® CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in both symptomatic...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading